AJP - Regulatory, Integrative and Comparative Physiology, Vol 260, Issue 6 1095-R1103, Copyright © 1991 by American Physiological Society

ARTICLES

Bradykinin increases myocardial contractility: relation to the Gregg phenomenon

P. A. Munch and J. C. Longhurst
Department of Medicine, University of California, San Diego, La Jolla 92037.

Bradykinin (BK) is reportedly produced in the heart during ischemia. Because BK has been shown to activate cardiac afferent nerves thought to be nocioceptors, we tested whether BK might alter myocardial shortening, which potentially could contribute to afferent nerve stimulation. In open-chest dogs, BK (1-10 micrograms) was injected into the left anterior descending (LAD) coronary artery while wall motion in the LAD and control circumflex regions was monitored. Wall motion was measured with midwall segment gauges (sonomicrometer crystals) placed in the hoop direction. Blood pressure, heart rate, left ventricular pressure, first derivative of left ventricular pressure, and LAD coronary flow also were monitored. At 15-20 s after injection, which was before circulation of the peptide caused blood pressure to change, BK decreased maximum end-diastolic and minimum end-systolic segment lengths and increased maximum shortening fraction in LAD region. No change was observed in circumflex region. The response was not eliminated by bilateral vagotomy or subsequent stellate ganglionectomy, indicating that it was not neurally mediated. The response closely paralleled changes in coronary flow, was mimicked by intracoronary injection of adenosine, and was reduced or absent if flow was already elevated by previous injection of adenosine. When BK eventually reached the systemic circulation, the resultant hypotension further reduced shortening in LAD region, with directionally similar effect in circumflex region. These results suggest that BK can increase regional shortening by enhancing coronary flow (Gregg phenomenon) as well as by altering global ventricular function through systemic hypotension. Such changes in shortening may contribute to stimulation of cardiac afferent nerves.

This article has been cited by other articles:

				G. J. Crystal, X. Zhou, S. Alam, A. Piotrowski, and G. Hu Lack of role for nitric oxide in cholinergic modulation of myocardial contractility in vivo Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H198 - H206. [Abstract] [Full Text] [PDF]

				R. Rastaldo, N. Paolocci, A. Chiribiri, C. Penna, D. Gattullo, and P. Pagliaro Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2823 - H2832. [Abstract] [Full Text] [PDF]

				P. Li, K. F. Pitsillides, S. V. Rendig, H.-L. Pan, and J. C. Longhurst Reversal of Reflex-Induced Myocardial Ischemia by Median Nerve Stimulation : A Feline Model of Electroacupuncture Circulation, March 31, 1998; 97(12): 1186 - 1194. [Abstract] [Full Text] [PDF]

				P. B. Anning, R. M. Grocott-Mason, M. J. Lewis, and A. M. Shah Enhancement of Left Ventricular Relaxation in the Isolated Heart by an Angiotensin-Converting Enzyme Inhibitor Circulation, November 1, 1995; 92(9): 2660 - 2665. [Abstract] [Full Text]

				R. D. Minshall, F. Nakamura, R. P. Becker, and S. F. Rabito Characterization of Bradykinin B2 Receptors in Adult Myocardium and Neonatal Rat Cardiomyocytes Circ. Res., May 1, 1995; 76(5): 773 - 780. [Abstract] [Full Text]